Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,934 | 1,049 | 92.1% |
| Consulting Fee | $1,200 | 1 | 6.5% |
| Education | $137.85 | 7 | 0.8% |
| Travel and Lodging | $107.40 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,516 | 185 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,483 | 133 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,399 | 7 | $0 (2021) |
| ABBVIE INC. | $1,239 | 76 | $0 (2024) |
| PFIZER INC. | $1,182 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,030 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $839.25 | 49 | $0 (2024) |
| Amgen Inc. | $794.25 | 47 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $734.61 | 83 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $687.95 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,909 | 108 | Novo Nordisk Inc ($309.64) |
| 2023 | $2,068 | 121 | AbbVie Inc. ($330.21) |
| 2022 | $2,706 | 143 | Novo Nordisk Inc ($401.73) |
| 2021 | $3,748 | 150 | Biohaven Pharmaceuticals, Inc. ($1,399) |
| 2020 | $1,993 | 120 | AstraZeneca Pharmaceuticals LP ($700.66) |
| 2019 | $1,720 | 112 | AstraZeneca Pharmaceuticals LP ($378.60) |
| 2018 | $2,153 | 162 | AstraZeneca Pharmaceuticals LP ($305.77) |
| 2017 | $2,081 | 142 | Novo Nordisk Inc ($297.12) |
All Payment Transactions
1,058 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Diabetes Care | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: DIABETES | ||||||
| 11/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.34 | General |
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Obesity | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: VACCINES | ||||||
| 10/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Gastroenterology | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $0.30 | General |
| 09/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 979 | 1,426 | $165,856 | $65,468 |
| 2022 | 16 | 1,166 | 1,710 | $174,724 | $75,937 |
| 2021 | 21 | 1,826 | 2,452 | $199,827 | $92,024 |
| 2020 | 21 | 1,378 | 1,968 | $194,896 | $75,630 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 224 | 385 | $83,565 | $28,515 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $29,208 | $13,883 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 112 | $16,208 | $5,963 | 36.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $8,000 | $5,375 | 67.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 221 | 396 | $7,524 | $3,302 | 43.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 43 | $4,085 | $3,021 | 74.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 95 | 170 | $4,930 | $1,601 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $2,068 | $1,328 | 64.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 30 | $7,350 | $1,144 | 15.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,056 | $664.01 | 62.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $720.00 | $461.88 | 64.2% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 29 | 31 | $806.00 | $119.35 | 14.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 35 | 42 | $336.00 | $92.40 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 232 | 407 | $78,551 | $30,355 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 172 | 172 | $39,388 | $21,269 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 130 | $16,900 | $6,896 | 40.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 57 | 57 | $5,415 | $3,828 | 70.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $5,200 | $3,620 | 69.6% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 11 | 12 | $3,000 | $1,683 | 56.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 62 | $2,728 | $1,660 | 60.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 89 | 170 | $4,930 | $1,594 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 246 | 470 | $8,930 | $1,378 | 15.4% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 35 | 36 | $1,584 | $1,309 | 82.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,038 | $687.23 | 22.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,056 | $654.80 | 62.0% |
About Dr. Richard Schlossberg, M.D
Dr. Richard Schlossberg, M.D is a Family Medicine healthcare provider based in Auburn, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962497941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Schlossberg, M.D has received a total of $18,379 in payments from pharmaceutical and medical device companies, with $1,909 received in 2024. These payments were reported across 1,058 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($16,934).
As a Medicare-enrolled provider, Schlossberg has provided services to 5,349 Medicare beneficiaries, totaling 7,556 services with total Medicare billing of $309,059. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Auburn, GA
- Active Since 09/15/2005
- Last Updated 10/07/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962497941
Products in Payments
- FARXIGA (Drug) $2,239
- NURTEC ODT (Drug) $1,814
- Ozempic (Drug) $1,072
- JARDIANCE (Drug) $832.73
- Livalo (Drug) $703.18
- VRAYLAR (Drug) $585.02
- UBRELVY (Drug) $428.86
- Kerendia (Drug) $420.91
- TRELEGY ELLIPTA (Drug) $417.01
- Vascepa (Drug) $386.16
- Rybelsus (Drug) $383.47
- CHANTIX (Drug) $345.06
- QULIPTA (Drug) $330.51
- Korlym (Drug) $302.06
- TRINTELLIX (Drug) $288.83
- TRULICITY (Drug) $281.06
- Otezla (Drug) $267.16
- XIFAXAN (Drug) $266.31
- XARELTO (Drug) $256.38
- Aimovig (Biological) $249.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Auburn
Dr. Mark Souder, Md, MD
Family Medicine — Payments: $26,799
Dr. Daniel Sewell, Md, MD
Family Medicine — Payments: $15,122
Dr. James Gauthier, M.d, M.D
Family Medicine — Payments: $11,790
Dr. Sarat Meka, Md, MD
Family Medicine — Payments: $10,718
Adam Duckett, Do, DO
Family Medicine — Payments: $8,084
Dr. Franklin Bufford, Md, MD
Family Medicine — Payments: $8,022